Field safety notices: HYPHEN BioMed
Manufacturer registered in EUDAMED: SRN FR-MF-000002214 ; country: France
9 authority publications by 2 authorities, from 31 Jul 2019 to 15 Nov 2024.
Latest notice: 15 Nov 2024, ANSM, Réactif PT-Phen LRT
Uneven depth of sources: BfArM followed since March 2026, MHRA since January 2025, IGJ fully since 2026, BASG partial. The absence of a notice before these dates proves nothing. A notice repeated by several authorities appears once per authority. Independent page, neither published nor endorsed by HYPHEN BioMed or by any authority; a matching error can be reported through the legal notice page and is corrected within two working days.
8 distinct corrective actions.
- Réactif PT-Phen LRTManufacturer matched by a similar name: check at the source.
Source : ANSM, informations de sécurité · collected 16 Nov 2026
- Réactif PT-Phen tm LRT
Source : ANSM, informations de sécurité · collected 16 Nov 2026
Corrective action: 2 publications by AEMPS, ANSM, from 30 Apr 2024 to 13 May 2024
- Kit ZYMUTES Total Protein S (II), referencia RK021B y UDI-DI 03663537083082
Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026
- Réactif Zymutest Total Protein S (ll)
Source : ANSM, informations de sécurité · collected 16 Nov 2026
- Réactifs Biophen Protein C LRT & Biophen Protein C 5
Source : ANSM, informations de sécurité · collected 16 Nov 2026
- Réactif Hemoclot Thrombin Time LRT
Source : ANSM, informations de sécurité · collected 16 Nov 2026
- Réactif Hemoclot Quanti. V-L
Source : ANSM, informations de sécurité · collected 16 Nov 2026
- Réactif Biophen Normal Control Plasma
Source : ANSM, informations de sécurité · collected 16 Nov 2026
- Réactifs Zymutest Anti-VIII MonoStrip IgG, Zymutest HIA IgG & Zymutest HIA Monostrip IgGAM
Source : ANSM, informations de sécurité · collected 16 Nov 2026